Literature DB >> 25387770

Magnetic resonance enterocolonography in detecting erosion and redness in intestinal mucosa of patients with Crohn's disease.

Hirokazu Sato1, Chiharu Tamura, Kazuyuki Narimatsu, Motonori Shimizu, Takeshi Takajyo, Masataka Yamashita, Yasushi Inoue, Hayato Ozaki, Hirotaka Furuhashi, Koji Maruta, Yuichi Yasutake, Kenichi Yoshikawa, Chikako Watanabe, Shunsuke Komoto, Kengo Tomita, Shigeaki Nagao, Soichiro Miura, Hiroshi Shinmoto, Ryota Hokari.   

Abstract

BACKGROUND AND AIM: In Crohn's disease (CD), assessment of disease activity and extension is important for clinical management. Endoscopy is the most reliable tool for evaluating disease activity in these patients and it distinguishes between lesions based on ulcer, erosion, and redness. Magnetic resonance imaging (MRI) is less invasive than endoscopy; however, the sensitivity of MRI in detecting lesions is believed to be lower, and whether MRI can detect milder lesions has not been studied. The aim of this study was to compare the detection ability of magnetic resonance enterocolonography (MREC) with ileocolonic endoscopy in patients with CD.
METHODS: A total of 27 patients with CD underwent both MREC and ileocolonoscopy. There were 55 lesions (18 ileum and 37 colon) endoscopically detected, and the findings of MREC were compared with each ileocolonoscopic finding to determine sensitivity and specificity.
RESULTS: For a positive lesion defined as having at least one of the following: wall thickness, edema, diffusion-weighted imaging (DWI) high intensity and relative contrast enhancement (RCE) on MREC, the sensitivities were 100% for ulcer, 84.6% for erosion, and 52.9% for redness, suggesting an ability to detect milder lesions such as erosion or redness. Moreover, RCE values were well correlated with the severity of endoscopically identified active lesions.
CONCLUSION: MREC findings may be useful not only for evaluation of ulcers, but also for detection of endoscopically identified milder lesions in CD, suggesting a clinical usefulness of MREC for disease detection and monitoring.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Crohn's disease; MR enterocolonography; colonic inflammation; endoscopy

Mesh:

Year:  2015        PMID: 25387770     DOI: 10.1111/jgh.12851

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Assessment of colon and bladder crosstalk in an experimental colitis model using contrast-enhanced magnetic resonance imaging.

Authors:  R A Towner; N Smith; D Saunders; S B Van Gordon; K R Tyler; A B Wisniewski; B Greenwood-Van Meerveld; R E Hurst
Journal:  Neurogastroenterol Motil       Date:  2015-08-24       Impact factor: 3.598

2.  Evaluation by MR Enterocolonography of Lansoprazole-induced Collagenous Colitis Accompanied with Protein-losing Enteropathy.

Authors:  Akinori Mizoguchi; Masaaki Higashiyama; Keisuke Ikeyama; Shin Nishii; Hisato Terada; Hirotaka Furuhashi; Takeshi Takajo; Koji Maruta; Yuichi Yasutake; Kazuhiko Shirakabe; Chikako Watanabe; Kengo Tomita; Shunsuke Komoto; Shigeaki Nagao; Soichiro Miura; Ryota Hokari
Journal:  Intern Med       Date:  2017-10-16       Impact factor: 1.271

Review 3.  A review of magnetic resonance enterography-based indices for quantification of Crohn's disease inflammation.

Authors:  Noa Rozendorn; Marianne Michal Amitai; Rami Abraham Eliakim; Uri Kopylov; Eyal Klang
Journal:  Therap Adv Gastroenterol       Date:  2018-04-13       Impact factor: 4.409

4.  Comparison of Conventional Ultrasound and Contrast Enhanced Magnetic Resonance (MR) Enterography in Evaluation Patients with Crohn's Disease.

Authors:  Bilal Imsirovic; Enver Zerem; Emir Guso; Muhamed Djedovic; Anesa Cengic; Rusmir Baljic; Zulejha Merhemic; Alma Efendic
Journal:  Acta Inform Med       Date:  2018-06

5.  Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease.

Authors:  Shintaro Sagami; Taku Kobayashi; Nao Kikkawa; Satoko Umeda; Masaru Nakano; Takahiko Toyonaga; Shinji Okabayashi; Ryo Ozaki; Toshifumi Hibi
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

6.  Lemann Index for Assessment of Crohn's Disease: Correlation with the Quality of Life, Endoscopic Disease Activity, Magnetic Resonance Index of Activity and C- Reactive Protein.

Authors:  Vestina Straksyte; Gediminas Kiudelis; Irina Gineikiene; Dainius Janciauskas; Algidas Basevicius; Saulius Lukosevicius; Limas Kupcinskas
Journal:  Open Med (Wars)       Date:  2019-11-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.